Molecularly targeted therapy for malignant glioma-Reference-Cited by-同舟云学术

Molecularly targeted therapy for malignant glioma

Published:2007 Issue:1 Volume:110 Page:13-24
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sathornsumetee Sith,Reardon David A.,Desjardins Annick,Quinn Jennifer A.,Vredenburgh James J.,Rich Jeremy N.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference91 articles.

1. CBTRUS, Statistical report: Primary brain tumors in the United States, 1998–2002. Chicago: Central Brain Tumor Registry of the United States (CBTRUS); 2006.

2. . World Health Organization classification of tumors. Pathology and genetics: Tumors of the nervous system. 2nd ed. Albany: WHO Publications Centre USA; 2000.

3. Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06☆

4. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

5. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma;Cancers;2024-05-11

2. LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC;Biologics: Targets and Therapy;2024-05

3. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis;Biochemical and Biophysical Research Communications;2024-04

4. Dysregulation of LINC00324 promotes poor prognosis in patients with glioma;PLOS ONE;2024-03-26

5. Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial;PLOS ONE;2024-03-26